Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Bypass vs Stent Strategy in Peroperatively Diagnosed Irresectable Pancreatic Cancer - A Prospective Randomized Multicenter Study

NCT01569282 is registered in ClinicalTrials.gov with Göteborg University as lead sponsor.

NCT NCT01569282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01569282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Bypass vs Stent Strategy in Peroperatively Diagnosed Irresectable Pancreatic Cancer - A Prospective Randomized Multicenter Study
Lead sponsor
Göteborg University
Phase
Not applicable
Overall status
Withdrawn
Start date
October 31, 2011
Completion date
October 31, 2015
Enrollment
0 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer, periampullary tumor